Answer:
The Dietary supplement health and education act does not allowed to Regulating the dietary supplements to be regulated by the FDA before they are marketed.
The probable negative out come of this disease include that unsafe substances can be added to the dietary substances and marketed without listed on label.
FDA must regulate and prove such substances is unsafe restrict it from the market.
Answer:
Explanation:
Advantages of Anticoagulant Therapy
Anticoagulant therapy remains the mainstay of medical therapy for deep venous thrombosis (DVT) because it is non-invasive, it treats most patients (approximately 90%) with no immediate demonstrable physical sequelae of DVT, it has a low risk of complications, and its outcome data demonstrates an improvement in morbidity and mortality. Meta-analyses of randomized trials of unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) have shown that they are similar, with a 4% risk of recurrent DVT, a 2% risk of pulmonary embolism (PE), and a 3% risk of major bleeding.
